A Role for Periostin Pathological Variants and Their Interaction with HSP70-1a in Promoting Pancreatic Cancer Progression and Chemoresistance
Yasuo Tsunetoshi, Fumihiro Sanada, Yuko Kanemoto, Kana Shibata, Atsushi Masamune, Yoshiaki Taniyama, Koichi Yamamoto, Ryuichi Morishita · 2024
Read A Role for Periostin Pathological Variants and Their Interaction with HSP70-1a in Promoting Pancreatic Cancer Progression and Chemoresistance by Yasuo Tsunetoshi, Fumihiro Sanada, Yuko Kanemoto, Kana Shibata, Atsushi Masamune, Yoshiaki Taniyama, Koichi Yamamoto, Ryuichi Morishita (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641934.txt.
Description
Pancreatic cancer hides in a dense scar-like stroma, and one stroma protein's altered forms may shield it from drugs. Yasuo Tsunetoshi and co-authors study those forms in a 2024 paper. The protein, periostin, is made mostly by cancer-linked fibroblasts around the tumor. One spliced form carrying a certain exon appears in both mouse and human tumors. Gene reading tied periostin-rich fibroblasts to matrix and signal genes.
Only the altered form grips a heat-shock partner protein. That grip rescued tumor cells from a standard drug's killing effect. Computer models show the exon changes the protein's shape and grip sites. The authors frame the form as a driver of drug resistance.
Catalog record
| CREATOR | Yasuo Tsunetoshi, Fumihiro Sanada, Yuko Kanemoto, Kana Shibata, Atsushi Masamune, Yoshiaki Taniyama, Koichi Yamamoto, Ryuichi Morishita |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |